HansBiomed Corporation (KOSDAQ: A042520)
Health Care · Biotechnology · KR
₩20,650.00
-2.82% today · +9.4% 1Y
HansBiomed Corporation (KOSDAQ: A042520) operates in the Biotechnology industry within the Health Care sector. The company is valued at $219.06M.
Over the last twelve months the share price has gained 9.4%, trading between 15.30K and 57.80K.
Tweenvest scores HansBiomed Corporation across four factors: quality 47/100, value 67/100, growth 51/100. Its strongest factor is value.
A042520 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $219.06M
- Revenue (TTM)
- $80.60M
- P/E
- —
- EPS
- -1,433.17
- Dividend yield
- —
- Beta (5Y)
- 2.02
- 52-week high
- ₩57,800.00
- 52-week low
- ₩15,300.00
- Avg volume (3M)
- —
- Shares outstanding
- 14.26M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Akebia Therapeutics, Inc.NasdaqCM: AKBA | $221.99M | $0.80 | -7.39% |
| Sionna Therapeutics, Inc.NasdaqGM: SION | $221.54M | $4.90 | -0.20% |
| OBI Pharma, Inc.TPEX: 4174 | $220.98M | NT$53.70 | +27.86% |
| ADC Therapeutics SANYSE: ADCT | $220.87M | $1.73 | 0.00% |
| Panacea Biotec LimitedNSEI: PANACEABIO | $218.50M | Rs345.25 | -3.84% |
| Transgene SAENXTPA: TNG | $214.67M | €0.70 | 0.00% |
| Beijing Biostar Pharmaceuticals Co., Ltd.SEHK: 2563 | $213.47M | HK$4.30 | -10.97% |
| Cartesian Therapeutics, Inc.NasdaqGM: RNAC | $213.45M | $7.06 | -4.14% |
Figures last refreshed Oct 11, 2026.